-
公开(公告)号:US06291691B1
公开(公告)日:2001-09-18
申请号:US09588933
申请日:2000-06-07
申请人: Robert A. Holton , Zhuming Zhang , Paul A. Clarke
发明人: Robert A. Holton , Zhuming Zhang , Paul A. Clarke
IPC分类号: C07D30514
CPC分类号: C07D305/14 , C07F7/1804 , C07F7/1892
摘要: Processes for the preparation of taxol and other taxanes through selective derivatization of the C(7) and C(10) hydroxyl groups of 10-DAB, particularly a novel process using a new strategy in which the C(10) hydroxyl group is protected or derivatized prior to the C(7) hydroxyl group; and the provision of C(7) and C(10) derivatized 10-DAB compounds.
摘要翻译: 通过选择性衍生10-DAB的C(7)和C(10)羟基来制备紫杉醇和其他紫杉烷的方法,特别是使用C(10)羟基被保护的新策略的新方法,或 在C(7)羟基之前衍生化; 并提供C(7)和C(10)衍生化的10-DAB化合物。
-
公开(公告)号:US07928233B2
公开(公告)日:2011-04-19
申请号:US12685748
申请日:2010-01-12
申请人: Li Chen , Xingchun Han , Song Yang , Zhuming Zhang
发明人: Li Chen , Xingchun Han , Song Yang , Zhuming Zhang
IPC分类号: C07D401/04 , A61K31/438
CPC分类号: C07D471/10
摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt, ester or enantiomer thereof wherein W, X, Y, V, R1 and R2 are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
摘要翻译: 提供下式的化合物或其药学上可接受的盐,酯或对映异构体,其中W,X,Y,V,R 1和R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。
-
公开(公告)号:US20100210674A1
公开(公告)日:2010-08-19
申请号:US12683468
申请日:2010-01-07
申请人: Jing Zhang , Zhuming Zhang
发明人: Jing Zhang , Zhuming Zhang
IPC分类号: A61K31/438 , C07D471/10 , A61P35/00
CPC分类号: C07D471/10
摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt or ester thereof wherein X, Y, R1, R2 are as herein described.The compounds have utility as antiproliferative agents, especially, as anticancer agents.
摘要翻译: 提供下式的化合物或其药学上可接受的盐或酯,其中X,Y,R 1,R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。
-
公开(公告)号:US07776875B2
公开(公告)日:2010-08-17
申请号:US12273035
申请日:2008-11-18
申请人: Li Chen , Xingchun Han , Yun He , Song Yang , Zhuming Zhang
发明人: Li Chen , Xingchun Han , Yun He , Song Yang , Zhuming Zhang
IPC分类号: A61K31/438 , C07D471/10
CPC分类号: C07D471/10
摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.
摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。
-
公开(公告)号:US07576082B2
公开(公告)日:2009-08-18
申请号:US11471363
申请日:2006-06-20
申请人: Kin-Chun Luk , Sung-Sau So , Jing Zhang , Zhuming Zhang
发明人: Kin-Chun Luk , Sung-Sau So , Jing Zhang , Zhuming Zhang
IPC分类号: A61K31/535 , A61K31/445 , A61K31/415 , A61K31/40 , C07D413/00 , C07D401/00 , C07D403/02 , C07D487/00 , C07D209/04
CPC分类号: C07D401/14 , C07D209/34 , C07D401/04 , C07D403/04
摘要: The invention describes compounds of the general formula I or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and X are herein described, a process for their manufacture, medicaments containing them as well as the use of these compounds as pharmaceutically active agents. The compounds show activity as antiproliferative agents and may be especially useful for the treatment of cancer.
摘要翻译: 本发明描述了通式I的化合物或其药学上可接受的盐,其中本文描述了R1,R2,R3和X,其制备方法,含有它们的药物以及这些化合物作为药物活性剂的用途。 该化合物显示作为抗增殖剂的活性,并且可能特别可用于治疗癌症。
-
公开(公告)号:US20090163512A1
公开(公告)日:2009-06-25
申请号:US12273035
申请日:2008-11-18
申请人: Li Chen , Xingchun Han , Yun He , Song Yang , Zhuming Zhang
发明人: Li Chen , Xingchun Han , Yun He , Song Yang , Zhuming Zhang
IPC分类号: A61K31/496 , C07D471/10 , A61K31/438
CPC分类号: C07D471/10
摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein.The compounds have utility as antiproliferative agents, especially, as anticancer agents.
摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。
-
公开(公告)号:US07427635B2
公开(公告)日:2008-09-23
申请号:US11202299
申请日:2005-08-11
申请人: Xin-Jie Chu , Nader Fotouhi , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Moliterni , Zhuming Zhang
发明人: Xin-Jie Chu , Nader Fotouhi , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Moliterni , Zhuming Zhang
IPC分类号: A61K31/427 , C07D417/12
CPC分类号: C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
摘要翻译: 本发明涉及可用于治疗以MEK多动症为特征的疾病的下式化合物。 因此,该化合物可用于治疗诸如癌症,认知和CNS障碍和炎症/自身免疫性疾病的疾病。
-
公开(公告)号:US07371869B2
公开(公告)日:2008-05-13
申请号:US11225950
申请日:2005-09-14
申请人: Robert Alan Goodnow, Jr. , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Anthony Moliterni , Zhuming Zhang
发明人: Robert Alan Goodnow, Jr. , Nicholas J. S. Huby , Norman Kong , Lee Apostle McDermott , John Anthony Moliterni , Zhuming Zhang
IPC分类号: A61K31/427 , C07D409/12
CPC分类号: C07D417/14 , C07D417/12
摘要: The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
-
公开(公告)号:US20060041146A1
公开(公告)日:2006-02-23
申请号:US11202299
申请日:2005-08-11
申请人: Xin-Jie Chu , Nader Fotouhi , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
发明人: Xin-Jie Chu , Nader Fotouhi , Nicholas Huby , Norman Kong , Lee McDermott , John Moliterni , Zhuming Zhang
IPC分类号: A61K31/427 , C07D417/02
CPC分类号: C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of the formula which are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as, cancer, cognative and CNS disorders and inflammatory/autoimmune diseases.
摘要翻译: 本发明涉及可用于治疗以MEK多动症为特征的疾病的下式化合物。 因此,该化合物可用于治疗诸如癌症,认知和CNS障碍和炎症/自身免疫性疾病的疾病。
-
-
-
-
-
-
-
-